One of the 59 healthcare decks in this library raised its Series C not by promising a breakthrough, but by building a nationwide network of in-person therapists — the slow, capital-intensive part of mental healthcare that faster-moving competitors skipped.

This library pulls together real fundraising decks from healthcare startups at every stage — from direct-to-patient mental health networks to the software companies healthcare operators run in the background.

It matters because healthcare founders have to clear a bar software founders don't: before an investor, a regulator, or a patient will trust the product, someone has to believe it won't cause harm.

Below, we look at how these decks establish that legitimacy — and how the evidence changes depending on whether the company touches patients directly or sells to the people who do.

Here's the full breakdown:

Inside you'll find:

Two Chairs' Series C deck, pictured above, opens with nothing but the name on a solid color field — no tagline, no product screenshot. The confidence comes from what's implied: this is a company big enough to not need to explain itself on slide one.

→ In a category where several venture-backed telehealth apps scaled fast and then ran into public scrutiny over care quality, betting on credentialed, in-person therapists and a careful matching process is a slower story to tell investors — but an easier one to defend later.

That trade-off shows up throughout the deck category: healthcare companies that lead with clinical rigor over growth velocity are making a specific bet about what actually earns a Series C, not just a press cycle.

Across the decks in this collection, a few things show up before the market-size slide gets to make its case:

→ The decks that skip this and jump straight to market size read, to a healthcare-literate investor, like the founders haven't sat with what could go wrong — which is itself a red flag in this category.

Not every healthcare deck is pitching a care product. Axle Health's Series A deck, pictured below, sells AI workforce management to home health and hospice agencies — software that schedules and routes the nurses, not a product a patient ever sees directly.

That's a fundamentally different trust problem. Axle Health doesn't need to convince a patient or a regulator that its own care is safe — it needs to convince a home health agency's operations team that the software won't break their business. The deck leans on operational metrics (hours saved, visits scheduled) instead of clinical outcomes.

→ “Picks and shovels” healthcare companies get to borrow legitimacy from the licensed providers they sell to, which is a real advantage — but it also means their pitch has to prove reliability and integration depth instead of care quality, since care quality was never their claim to make.

Regardless of whether a company touches patients directly, most decks in this library carry some version of a compliance or trust slide: HIPAA handling, state licensure status, clinical advisory involvement, or a named pilot partner willing to vouch for the product.

Software and fintech decks have their own versions of this — uptime, security, regulatory status — but healthcare's version is the hardest to fake, because the cost of getting it wrong is a person, not a chargeback.

The lesson isn't to copy Two Chairs' minimalist cover slide or Axle Health's operations-metrics framing. It's to identify exactly who needs to trust you — the patient, the regulator, or the healthcare operator buying your software — and to put that evidence before the growth story, not after it.

Every company named above — plus more than 50 others spanning pre-seed to growth stage, from Thoughtful AI to Crosby Health — is in the spreadsheet and deck library below, with the stage, round size, and business model for each one.

The best part is below.

Members get the full breakdown plus every resource we publish: decks, fundraising playbooks, and the AI tools worth your time.

Build yourself to build what lasts.